About Nippon ChemiPhar
Nippon ChemiPhar is a publicly listed company based in Tokyo (Japan) founded in 1950. The company has 855 employees. Its website chemiphar.co.jp draws about 11 thousand monthly visits. Nippon ChemiPhar offers products and services including Generic Drugs and Clinical Inspection Drugs. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Nippon Chemiphar Co., Ltd.
Company details
Manufacturer of engineered components and systems for mobile and industrial machinery. It designs and manufactures hydraulics, electrification, fluid conveyance, electronic controls, and software solutions. These solutions are engineered with a focus on quality, reliability, and safety. The company partners with customers to solve machine challenges, increasing productivity and efficiency while reducing emissions. Its offerings support a wide range of industries. Sustainability is a core business principle, driving efforts in decarbonization, circularity, and diversity, equity, and inclusion.
- Headquarters Tokyo, Japan
- Employees 855
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website chemiphar.co.jp
- Legal Name Nippon Chemiphar Co., Ltd.
- Annual Revenue$207.46 M (USD)1.6as on Mar 31, 2026
- Net Profit$1.24 M (USD)-32.65as on Mar 31, 2026
- EBITDA$10.91 M (USD)-12.35as on Mar 31, 2026
- Employee Count855
Products & Services of Nippon ChemiPhar
Nippon ChemiPhar offers a comprehensive portfolio of products and services, including Generic Drugs and Clinical Inspection Drugs.
Generic drugs are manufactured and distributed for various medical treatments.
Clinical inspection drugs are supplied for diagnostic and healthcare purposes.
IPO & Listings of Nippon ChemiPhar
Nippon ChemiPhar is a publicly listed company on the TSE with ticker symbol 4539 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date01 Oct 1971
- Listed onTSE: 4539
- Listed entityNippon Chemiphar Co., Ltd.
- Exchange sectorHealth technology
- ISINJP3701600003
- Share price1,542.00 JPY (-0.19% on the day) · 2026-10-14
- Market capitalisation5,578,191,708.00 JPY
- Price to earnings11.0
- EPS (diluted, trailing year)-34.18 JPY
- Dividend yield3.2%
- Volume (last session)3,800
Financials of Nippon ChemiPhar
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 33.09B JPY | 198.0M JPY | 1.74B JPY |
| 2024 | 32.57B JPY | 294.0M JPY | 1.98B JPY |
| 2023 | 30.75B JPY | -180.0M JPY | 965.0M JPY |
| 2022 | 31.56B JPY | 339.0M JPY | 1.26B JPY |
| 2021 | 32.51B JPY | 700.0M JPY | 2.41B JPY |
Detailed financial statements for Nippon ChemiPhar
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Nippon ChemiPhar
The website of Nippon ChemiPhar (chemiphar.co.jp) receives about 11.3K visits a month and ranks #1,681,821 among all websites worldwide, #2,271 in Biotechnology and Pharmaceuticals.
- Monthly visits11.3K
▼ 16.7% vs previous month
- Unique visitors6.8K
per month
- Global rank#1,681,821
among all websites
- Category rank#2,271
Health · Biotechnology and Pharmaceuticals
- Bounce rate48%
- Pages per visit2.2
- Average visit1 min 31 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with Nippon ChemiPhar. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nc-medical.com | nc-medical.com | 100% | #1,412,918 | – | |
ohkuraseiyaku.com | ohkuraseiyaku.com | 94% | – | ||
snbl.com | snbl.com | 90% | #1,582,009 | – | |
fri.fujifilm.co.jp | fri.fujifilm.co.jp | 88% | – | ||
| zeria.co.jp | 88% | 78.7K | #362,505 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for Nippon ChemiPhar
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nippon Chemiphar
Complete news archive for Nippon ChemiPhar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nippon ChemiPhar
Nippon ChemiPhar was founded in 1950.
Nippon ChemiPhar is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Nippon ChemiPhar has 855 employees.
Annual revenue of Nippon ChemiPhar is $207.46M as on Mar 31, 2026.
Manufacturer of engineered components and systems for mobile and industrial machinery. It designs and manufactures hydraulics, electrification, fluid conveyance, electronic controls, and software solutions. These solutions are engineered with a focus on quality, reliability, and safety. The company partners with customers to solve machine challenges, increasing productivity and efficiency while reducing emissions. Its offerings support a wide range of industries. Sustainability is a core business principle, driving efforts in decarbonization, circularity, and diversity, equity, and inclusion.
Nippon ChemiPhar offers Generic Drugs and Clinical Inspection Drugs.
Yes, Nippon ChemiPhar is publicly traded on TSE under the ticker symbol 4539.
Nippon ChemiPhar operates through Nippon Chemiphar Co., Ltd.